Constantino III Roberto López-Macías

This study shows that antibodies alone can limit Salmonella infection, but their effectiveness is enhanced by complement and macrophages.

This study evaluates two SARS-CoV-2 vaccines, AVX/COVID-12 (V-Wu) and V-BA, showing V-BA provides better protection against Omicron subvariants while V-Wu offers broader coverage against multiple variants.

This study shows that OMVs with different O-antigen lengths induce similar protection against Salmonella infections, and boosting enhances cross-protection.

This paper evaluates the AVX/COVID-12 vaccine's ability to activate T cells and bind antibodies from vaccinated individuals and SARS-CoV-2-infected patients.

The paper predicts B and T cell epitopes in SARS-CoV-2 proteins and analyzes their conservation across coronaviruses to assess cross-reactivity potential between variants and other coronaviruses.